{"count": 9, "results": [{"_id": "21118403", "pmid": 21118403, "title": "Haemostatic effects of simvastatin in subjects with impaired glucose tolerance.", "journal": "Intern Med J", "authors": ["Krysiak R", "Okopien B"], "date": "2011-06-01T00:00:00Z", "doi": "10.1111/j.1445-5994.2010.02395.x", "meta_date_publication": "2011 Jun", "meta_volume": "41", "meta_issue": "6", "meta_pages": "473-81", "score": 50083.824, "text_hl": "Haemostatic effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in subjects with @<m>DISEASE_Glucose_Intolerance</m> @DISEASE_MESH:D018149 @@@impaired glucose tolerance@@@.", "citations": {"NLM": "Krysiak R, Okopien B. Haemostatic effects of simvastatin in subjects with impaired glucose tolerance. Intern Med J. 2011 Jun;41(6):473-81. PMID: 21118403", "BibTeX": "@article{21118403, title={Haemostatic effects of simvastatin in subjects with impaired glucose tolerance.}, author={Krysiak R and Okopien B}, journal={Intern Med J}, volume={41}, number={6}, pages={473-81}}"}}, {"_id": "23287371", "pmid": 23287371, "title": "Simvastatin effects on skeletal muscle: relation to decreased mitochondrial function and glucose intolerance.", "journal": "J Am Coll Cardiol", "authors": ["Larsen S", "Stride N", "Hey-Mogensen M", "Hansen CN", "Bang LE", "Bundgaard H", "Nielsen LB", "Helge JW", "Dela F"], "date": "2013-01-08T00:00:00Z", "doi": "10.1016/j.jacc.2012.09.036", "meta_date_publication": "2013 Jan 8", "meta_volume": "61", "meta_issue": "1", "meta_pages": "44-53", "score": 50076.504, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ effects on skeletal muscle: relation to decreased mitochondrial function and @<m>DISEASE_Glucose_Intolerance</m> @DISEASE_MESH:D018149 @@@glucose intolerance@@@.", "citations": {"NLM": "Larsen S, Stride N, Hey-Mogensen M, Hansen CN, Bang LE, Bundgaard H, Nielsen LB, Helge JW, Dela F. Simvastatin effects on skeletal muscle: relation to decreased mitochondrial function and glucose intolerance. J Am Coll Cardiol. 2013 Jan 8;61(1):44-53. PMID: 23287371", "BibTeX": "@article{23287371, title={Simvastatin effects on skeletal muscle: relation to decreased mitochondrial function and glucose intolerance.}, author={Larsen S and Stride N and Hey-Mogensen M and Hansen CN and Bang LE and Bundgaard H and Nielsen LB and Helge JW and Dela F}, journal={J Am Coll Cardiol}, volume={61}, number={1}, pages={44-53}}"}}, {"_id": "30276217", "pmid": 30276217, "pmcid": "PMC6157137", "title": "Simvastatin-Induced Insulin Resistance May Be Linked to Decreased Lipid Uptake and Lipid Synthesis in Human Skeletal Muscle: the LIFESTAT Study", "journal": "J Diabetes Res", "authors": ["Larsen S", "Vigelsø A", "Dandanell S", "Prats C", "Dela F", "Helge JW"], "date": "2018-09-12T00:00:00Z", "doi": "10.1155/2018/9257874", "meta_date_publication": "2018", "meta_volume": "2018", "meta_issue": "", "meta_pages": "9257874", "score": 50062.26, "text_hl": " A prevalent side-effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ is attenuated @<m>DISEASE_Glucose_Intolerance</m> @DISEASE_MESH:D018149 @@@glucose@@@ homeostasis. ", "citations": {"NLM": "Larsen S, Vigelsø A, Dandanell S, Prats C, Dela F, Helge JW. Simvastatin-Induced Insulin Resistance May Be Linked to Decreased Lipid Uptake and Lipid Synthesis in Human Skeletal Muscle: the LIFESTAT Study J Diabetes Res. 2018;2018():9257874. PMID: 30276217", "BibTeX": "@article{30276217, title={Simvastatin-Induced Insulin Resistance May Be Linked to Decreased Lipid Uptake and Lipid Synthesis in Human Skeletal Muscle: the LIFESTAT Study}, author={Larsen S and Vigelsø A and Dandanell S and Prats C and Dela F and Helge JW}, journal={J Diabetes Res}, volume={2018}, pages={9257874}}"}}, {"_id": "30859212", "pmid": 30859212, "title": "Simvastatin Inhibits L-Type Ca2+-Channel Activity Through Impairment of Mitochondrial Function.", "journal": "Toxicol Sci", "authors": ["Curry L", "Almukhtar H", "Alahmed J", "Roberts R", "Smith PA"], "date": "2019-06-01T00:00:00Z", "doi": "10.1093/toxsci/kfz068", "meta_date_publication": "2019 Jun 1", "meta_volume": "169", "meta_issue": "2", "meta_pages": "543-552", "score": 50059.527, "text_hl": "In this study, we investigated whether the @<m>DISEASE_Glucose_Intolerance</m> @DISEASE_MESH:D018149 @@@glucose intolerance@@@ associated with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ is also mediated via adverse effects on mETC in pancreatic beta-cells because mitochondrial respiration underlies insulin secretion from these cells, an effect in part mediated by promotion of Ca2+ influx via opening of voltage-gated Ca2+ channels (VGCCs). ", "citations": {"NLM": "Curry L, Almukhtar H, Alahmed J, Roberts R, Smith PA. Simvastatin Inhibits L-Type Ca2+-Channel Activity Through Impairment of Mitochondrial Function. Toxicol Sci. 2019 Jun 1;169(2):543-552. PMID: 30859212", "BibTeX": "@article{30859212, title={Simvastatin Inhibits L-Type Ca2+-Channel Activity Through Impairment of Mitochondrial Function.}, author={Curry L and Almukhtar H and Alahmed J and Roberts R and Smith PA}, journal={Toxicol Sci}, volume={169}, number={2}, pages={543-552}}"}}, {"_id": "31217552", "pmid": 31217552, "pmcid": "PMC6584635", "title": "Statins exacerbate glucose intolerance and hyperglycemia in a high sucrose fed rodent model", "journal": "Sci Rep", "authors": ["Seshadri S", "Rapaka N", "Prajapati B", "Mandaliya D", "Patel S", "Muggalla CS", "Kapadia B", "Babu PP", "Misra P", "Saxena U"], "date": "2019-06-19T00:00:00Z", "doi": "10.1038/s41598-019-45369-8", "meta_date_publication": "2019 Jun 19", "meta_volume": "9", "meta_issue": "1", "meta_pages": "8825", "score": 50054.93, "text_hl": "We utilized two statins: @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, the most prescribed statins to delineate potential role in @<m>DISEASE_Glucose_Intolerance</m> @DISEASE_MESH:D018149 @@@glucose intolerance@@@.", "citations": {"NLM": "Seshadri S, Rapaka N, Prajapati B, Mandaliya D, Patel S, Muggalla CS, Kapadia B, Babu PP, Misra P, Saxena U. Statins exacerbate glucose intolerance and hyperglycemia in a high sucrose fed rodent model Sci Rep. 2019 Jun 19;9(1):8825. PMID: 31217552", "BibTeX": "@article{31217552, title={Statins exacerbate glucose intolerance and hyperglycemia in a high sucrose fed rodent model}, author={Seshadri S and Rapaka N and Prajapati B and Mandaliya D and Patel S and Muggalla CS and Kapadia B and Babu PP and Misra P and Saxena U}, journal={Sci Rep}, volume={9}, number={1}, pages={8825}}"}}, {"_id": "22935083", "pmid": 22935083, "title": "The effect of fenofibrate on lymphocyte release of proinflammatory cytokines and systemic inflammation in simvastatin-treated patients with atherosclerosis and early glucose metabolism disturbances.", "journal": "Basic Clin Pharmacol Toxicol", "authors": ["Krysiak R", "Gdula-Dymek A", "Okopien B"], "date": "2013-03-01T00:00:00Z", "doi": "10.1111/bcpt.12003", "meta_date_publication": "2013 Mar", "meta_volume": "112", "meta_issue": "3", "meta_pages": "198-202", "score": 50050.5, "text_hl": "The study included 47 @DISEASE_Atherosclerosis @DISEASE_MESH:D050197 @@@atherosclerotic@@@ @SPECIES_9606 @@@patients@@@ with the concomitant presence of @DISEASE_Hypoglycemia @DISEASE_MESH:D007003 @@@impaired fasting glucose@@@ and @<m>DISEASE_Glucose_Intolerance</m> @DISEASE_MESH:D018149 @@@impaired glucose tolerance@@@ already receiving @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ treatment (40 mg daily) who were allocated to one of two groups treated for 90 days with, respectively, @CHEMICAL_Fenofibrate @CHEMICAL_MESH:D011345 @@@fenofibrate@@@ (200 mg daily) or placebo. ", "citations": {"NLM": "Krysiak R, Gdula-Dymek A, Okopien B. The effect of fenofibrate on lymphocyte release of proinflammatory cytokines and systemic inflammation in simvastatin-treated patients with atherosclerosis and early glucose metabolism disturbances. Basic Clin Pharmacol Toxicol. 2013 Mar;112(3):198-202. PMID: 22935083", "BibTeX": "@article{22935083, title={The effect of fenofibrate on lymphocyte release of proinflammatory cytokines and systemic inflammation in simvastatin-treated patients with atherosclerosis and early glucose metabolism disturbances.}, author={Krysiak R and Gdula-Dymek A and Okopien B}, journal={Basic Clin Pharmacol Toxicol}, volume={112}, number={3}, pages={198-202}}"}}, {"_id": "30931486", "pmid": 30931486, "title": "Selective inhibition of intestinal 5-HT improves neurobehavioral abnormalities caused by high-fat diet mice.", "journal": "Metab Brain Dis", "authors": ["Pan Q", "Liu Q", "Wan R", "Kalavagunta PK", "Liu L", "Lv W", "Qiao T", "Shang J", "Wu H"], "date": "2019-06-01T00:00:00Z", "doi": "10.1007/s11011-019-0392-x", "meta_date_publication": "2019 Jun", "meta_volume": "34", "meta_issue": "3", "meta_pages": "747-761", "score": 50049.453, "text_hl": "@CHEMICAL_LP533401 @CHEMICAL_MESH:C548240 @@@LP533401@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SIM@@@ could significantly improve the @<m>DISEASE_Glucose_Intolerance</m> @DISEASE_MESH:D018149 @@@impaired glucose tolerance@@@, while BZ had no significant effect. (2) @CHEMICAL_LP533401 @CHEMICAL_MESH:C548240 @@@LP533401@@@, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SIM@@@ and BZ alleviated @DISEASE_Depressive_Disorder @DISEASE_MESH:D003866 @@@depression@@@-like behavior of HFD @SPECIES_10090 @@@mice@@@ in OFT, TST, FST and SPT. (3) @CHEMICAL_LP533401 @CHEMICAL_MESH:C548240 @@@LP533401@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SIM@@@ reversed the inhibition of @GENE_TPH2 @GENE_216343 @@@Tryptophan Hydroxylase 2@@@, @GENE_TPH2 @GENE_216343 @@@Tph2@@@ gene expression and the activation of Indoleamine 2,3-dioxy-Genase, @GENE_IDO1 @GENE_15930 @@@IDO@@@ expression in HFD-treated brain, whereas BZ did not. (4) @CHEMICAL_LP533401 @CHEMICAL_MESH:C548240 @@@LP533401@@@, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SIM@@@ and BZ restored the inhibitory expression of @GENE_HTR1A @GENE_15550 @@@5-HT1A receptor@@@ in HFD hippocampus. ", "citations": {"NLM": "Pan Q, Liu Q, Wan R, Kalavagunta PK, Liu L, Lv W, Qiao T, Shang J, Wu H. Selective inhibition of intestinal 5-HT improves neurobehavioral abnormalities caused by high-fat diet mice. Metab Brain Dis. 2019 Jun;34(3):747-761. PMID: 30931486", "BibTeX": "@article{30931486, title={Selective inhibition of intestinal 5-HT improves neurobehavioral abnormalities caused by high-fat diet mice.}, author={Pan Q and Liu Q and Wan R and Kalavagunta PK and Liu L and Lv W and Qiao T and Shang J and Wu H}, journal={Metab Brain Dis}, volume={34}, number={3}, pages={747-761}}"}}, {"_id": "17273659", "pmid": 17273659, "title": "Are the beneficial cardiovascular effects of simvastatin and metformin also associated with a hormone-dependent mechanism improving insulin sensitivity?", "journal": "Braz J Med Biol Res", "authors": ["Bulcão C", "Giuffrida FM", "Ribeiro-Filho FF", "Ferreira SR"], "date": "2007-02-01T00:00:00Z", "meta_date_publication": "2007 Feb", "meta_volume": "40", "meta_issue": "2", "meta_pages": "229-35", "score": 50048.816, "text_hl": "Forty-one subjects with BMI >25 kg/m(2) and @DISEASE_Hypoglycemia @DISEASE_MESH:D007003 @@@impaired fasting glucose@@@ or @<m>DISEASE_Glucose_Intolerance</m> @DISEASE_MESH:D018149 @@@impaired glucose tolerance@@@ were randomized to take @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, 20 mg/day (N = 20) or @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@, 1.7 g/day (N = 21) for 16 weeks. ", "citations": {"NLM": "Bulcão C, Giuffrida FM, Ribeiro-Filho FF, Ferreira SR. Are the beneficial cardiovascular effects of simvastatin and metformin also associated with a hormone-dependent mechanism improving insulin sensitivity? Braz J Med Biol Res. 2007 Feb;40(2):229-35. PMID: 17273659", "BibTeX": "@article{17273659, title={Are the beneficial cardiovascular effects of simvastatin and metformin also associated with a hormone-dependent mechanism improving insulin sensitivity?}, author={Bulcão C and Giuffrida FM and Ribeiro-Filho FF and Ferreira SR}, journal={Braz J Med Biol Res}, volume={40}, number={2}, pages={229-35}}"}}, {"_id": "17610348", "pmid": 17610348, "title": "Effects of simvastatin and metformin on inflammation and insulin resistance in individuals with mild metabolic syndrome.", "journal": "Am J Cardiovasc Drugs", "authors": ["Bulcão C", "Ribeiro-Filho FF", "Sañudo A", "Roberta Ferreira SG"], "date": "2007-01-01T00:00:00Z", "doi": "10.2165/00129784-200707030-00007", "meta_date_publication": "2007", "meta_volume": "7", "meta_issue": "3", "meta_pages": "219-24", "score": 50045.76, "text_hl": "METHODS: Forty-one subjects with body mass index (BMI) 25-39.9 kg/m(2) and @<m>DISEASE_Glucose_Intolerance</m> @DISEASE_MESH:D018149 @@@impaired glucose tolerance@@@ were randomized to receive @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ or @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@ for 16 weeks. ", "citations": {"NLM": "Bulcão C, Ribeiro-Filho FF, Sañudo A, Roberta Ferreira SG. Effects of simvastatin and metformin on inflammation and insulin resistance in individuals with mild metabolic syndrome. Am J Cardiovasc Drugs. 2007;7(3):219-24. PMID: 17610348", "BibTeX": "@article{17610348, title={Effects of simvastatin and metformin on inflammation and insulin resistance in individuals with mild metabolic syndrome.}, author={Bulcão C and Ribeiro-Filho FF and Sañudo A and Roberta Ferreira SG}, journal={Am J Cardiovasc Drugs}, volume={7}, number={3}, pages={219-24}}"}}]}